Loss of murine tumor thymidine kinase activity in vivo following 5-fluorouracil (FUra) treatment by incorporation of FUra into RNA
- 27 November 1991
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 42 (12) , 2369-2375
- https://doi.org/10.1016/0006-2952(91)90243-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cellular pharmacology of 5-fluorouracil in a human colon adenocarcinoma cell line selected for thymidine kinase deficiencyBiochemical Pharmacology, 1990
- Metabolism and mechanism of action of 5-fluorouracilPharmacology & Therapeutics, 1990
- 5-Fluorouracil substitution alters pre-mRNA splicing in vitro.Journal of Biological Chemistry, 1988
- Relationship between 5-fluoro-2′-deoxyuridylate, 2′-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomasBiochemical Pharmacology, 1986
- [23] Ornithine decarboxylase (mouse kidney)Published by Elsevier ,1983
- Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU) RNACancer, 1980
- [46] Deoxythymidine kinase in regenerating rat liverPublished by Elsevier ,1978
- Rapid determination of nucleoside kinase and nucleotidase activities with tritium-labeled substratesAnalytical Biochemistry, 1969
- An Isotopic Assay for Thymidylate Synthetase*Biochemistry, 1966
- A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acidBiochemical Journal, 1956